Get started
Author

Muhammad Kashif

Observed names: M. Kashif, Mahmood Kashif, Mohammed S Kashif, Muhammad T. Kashif
Observed institutions: Aga Khan University, Uppsala University, Midwestern University, Karolinska University Hospital, Uppsala University Hospital, Ayub Medical College, University of Lahore, COMSATS University Islamabad, Christian Medical College, Vellore, University of Karachi, Riphah International University, Allama Iqbal Medical College, Lady Reading Hospital, King Abdulaziz Medical City, Aga Khan University Hospital, University of Health Sciences Lahore, Karolinska Institutet, Armed Forces Hospital, Tabba Heart Institute, M.S. Ramaiah Medical College, University of Jhang, National Guard Health Affairs, The University of Texas Medical Branch at Galveston, University of Veterinary and Animal Sciences
ORCID: 0000-0002-7545-8548
Observed ORCID: 0000-0002-7545-8548
OpenAlex ID: A5100684351
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
2019 · Clotilde Wiel, Kristell Le Gal, et al. · Cell · 577
MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework
2023 · Muhammad Shoaib, Amjad Islam Aqib, et al. · Frontiers in Microbiology · 168
PDF
ROS-lowering doses of vitamins C and A accelerate malignant melanoma metastasis
2023 · Muhammad Kashif, Haidong Yao, et al. · Redox Biology · 56
In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
2015 · M. Kashif, C. Andersson, et al. · Scientific Reports · 31
PDF
A small-molecule ICMT inhibitor delays senescence of Hutchinson-Gilford progeria syndrome cells
2021 · Xue Chen, Haidong Yao, et al. · eLife · 27
Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism
2017 · Muhammad Kashif, Claes Andersson, et al. · Oncotarget · 20
PDF
A Pragmatic Definition of Therapeutic Synergy Suitable for Clinically Relevant In Vitro Multicompound Analyses
2014 · Muhammad Kashif, Claes Andersson, et al. · Molecular Cancer Therapeutics · 18
Unlocking the anti‐diabetic potential of Gymnema sylvestre , Trigonella foenum‐graecum , and their combination thereof: An in‐vivo evaluation
2023 · Muhammad Kashif, Amar Nasir, et al. · Food Science & Nutrition · 17
Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14)
2021 · Hareth Nahi, Muhammad Kashif, et al. · American Journal of Hematology · 17
PDF
Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy
2022 · Katharina H. Susek, Ysabel A. Schwietzer, et al. · Cancer Immunology Immunotherapy · 13
PDF
Shake It Up Baby Now: The Changing Focus on TWIST1 and Epithelial to Mesenchymal Transition in Cancer and Other Diseases
2023 · Dureali Mirjat, Muhammad Kashif, et al. · International Journal of Molecular Sciences · 12
PDF
Lumpy Skin Disease: An insights in Pakistan
2022 · Muhammad Jamil, Noman Latif, et al. · Pakistan Journal of Medical and Health Sciences · 12
PDF
Antibody response to COVID ‐19 mRNA vaccine ( Comirnaty ) in myeloma patients treated with high‐dose melphalan and/or immunotherapy
2021 · Sandra Lockmer, Katarina Uttervall, et al. · American Journal of Hematology · 10
PDF
Targeting RAS‐converting enzyme 1 overcomes senescence and improves progeria‐like phenotypes of ZMPSTE24 deficiency
2020 · Haidong Yao, Xue Chen, et al. · Aging Cell · 10
PDF
A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosis
2023 · Haidong Yao, Xue Chen, et al. · Cell Reports · 9
PDF
Adaptive Framework to Manage Multiple Teams Using Agile Methodologies
2017 · M. Rizwan Jameel Qureshi, M. Kashif · International Journal of Modern Education and Computer Science · 9
PDF
Global series: Complex regional pain syndrome: abstracts from the International Association for the Study of Pain complex regional pain syndrome SIG virtual symposia 2021
2023 · Jennifer S. Lewis, Muhammad Kashif, et al. · PAIN Reports · 7
Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
2022 · Katarina Uttervall, Hareth Nahi, et al. · Blood · 7
Status of treatment strategies for Hutchinson–Gilford progeria syndrome with a focus on prelamin: A posttranslational modification
2022 · Xue Chen, Haidong Yao, et al. · Basic & Clinical Pharmacology & Toxicology · 7
PDF
Cohort profile: the Pregnancy Risk Infant Surveillance and Measurement Alliance (PRISMA) – Pakistan
2023 · Sabahat Naz, Ali Jaffar, et al. · BMJ Open · 6
Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care
2022 · Gabriel Afram, Roza Chaireti, et al. · European Journal Of Haematology · 5
PDF
Minimal residual disease status is the prognostic determinant following high‐dose treatment for patients with multiple myeloma
2023 · Hareth Nahi, Gabriel Afram, et al. · Cancer Medicine · 4
PDF
Medicinal Plants: An Insight into Wound Healing
2022 · Fateh Ullah, Muhammad Kashif, et al. · The Healer Journal of Physiotherapy and Rehabilitation Sciences · 4
PDF
Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia
2016 · A. Österroos, M. Kashif, et al. · Biochemical Pharmacology · 4
Role of Autologous Nanofat Grafting in the Treatment of Post Acne and Post Burn Scarring of the Face
2024 · Firdous Khan, Muhammad Kashif, et al. · Journal of Ayub Medical College Abbottabad · 3
PDF
Works count: 86
Citation count: 1,088
H-index: 12
I10-index: 14
Year
Topic
Type